Palisade Bio (PALI) Operating Margin Growth (3y) (2014 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.21 Mn |
| Dec 31, 2020 | -12.89 Mn |
| Sep 30, 2020 | 3.09 Mn |
| Jun 30, 2020 | 9.51 Mn |
| Mar 31, 2020 | 13.62 Mn |
| Dec 31, 2019 | -2.07 Mn |
| Sep 30, 2019 | 11.17 Mn |
| Jun 30, 2019 | 12.91 Mn |
| Mar 31, 2019 | 15.11 Mn |
| Dec 31, 2018 | 10.19 Mn |
| Sep 30, 2018 | 12.46 Mn |
| Jun 30, 2018 | 19.90 Mn |
| Mar 31, 2018 | 6.42 Mn |
| Dec 31, 2017 | 9.86 Mn |
| Sep 30, 2017 | -2.14 Mn |
| Jun 30, 2017 | -9.85 Mn |
| Mar 31, 2017 | -4.50 Mn |
| Dec 31, 2016 | 4.59 Mn |
| Sep 30, 2016 | -5.13 Mn |
| Jun 30, 2016 | -2.39 Mn |
| Mar 31, 2016 | -24.65 Mn |
| Dec 31, 2015 | -6.50 Mn |
| Sep 30, 2015 | -20.64 Mn |
| Jun 30, 2015 | -19.67 Mn |
| Mar 31, 2015 | -15.66 Mn |
| Dec 31, 2014 | -9.86 Mn |
| Sep 30, 2014 | -7.90 Mn |